Genomic Valley Biotech Limited

BSE:539206 Stock Report

Market Cap: ₹251.1m

Genomic Valley Biotech Past Earnings Performance

Past criteria checks 5/6

Genomic Valley Biotech has been growing earnings at an average annual rate of 21.4%, while the Professional Services industry saw earnings growing at 23.7% annually. Revenues have been growing at an average rate of 11.5% per year. Genomic Valley Biotech's return on equity is 6.3%, and it has net margins of 60.2%.

Key information

21.4%

Earnings growth rate

21.4%

EPS growth rate

Professional Services Industry Growth19.8%
Revenue growth rate11.5%
Return on equity6.3%
Net Margin60.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Genomic Valley Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:539206 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244210
30 Jun 243100
31 Mar 242000
31 Dec 23121110
30 Sep 2318210
30 Jun 2317210
31 Mar 2327620
31 Dec 2217-220
30 Sep 2211720
30 Jun 2211620
31 Mar 221020
31 Dec 211-510
30 Sep 212-610
30 Jun 212-510
31 Mar 212-610
31 Dec 205010
30 Sep 206110
30 Jun 207110
31 Mar 208320
31 Dec 199320
30 Sep 199230
30 Jun 1910240
31 Mar 1910230
31 Dec 189130
30 Sep 187040
30 Jun 187030
31 Mar 186030
31 Dec 175030
30 Sep 175030
30 Jun 174-130
31 Mar 174-130
31 Dec 163-320
30 Sep 163-220
30 Jun 162-310
31 Mar 161-310
31 Dec 151-210
30 Sep 151-210
30 Jun 150010
31 Mar 150000
31 Dec 141010
30 Sep 141010
30 Jun 141010
31 Mar 141010
31 Dec 131000

Quality Earnings: 539206 has high quality earnings.

Growing Profit Margin: 539206's current net profit margins (60.2%) are higher than last year (9.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 539206's earnings have grown significantly by 21.4% per year over the past 5 years.

Accelerating Growth: 539206's earnings growth over the past year (35.4%) exceeds its 5-year average (21.4% per year).

Earnings vs Industry: 539206 earnings growth over the past year (35.4%) exceeded the Professional Services industry 19.4%.


Return on Equity

High ROE: 539206's Return on Equity (6.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 08:53
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Genomic Valley Biotech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution